Photo of Katie Porter
D United States House · District 47 · California

Rep. Katie Porter

Compare
Total votes
2,168
all sessions
Attendance
93%
152 missed
Lower than 95% of chamber peers
With party
98%
of cast votes
Higher than 78% of chamber peers
Bipartisan score
1%
crosses aisle rarely
Lower than 78% of chamber peers
Sponsored
1,522
bills & resolutions
Higher than 96% of chamber peers
Committees
0
assignments
1,522 bills and resolutions

Sponsored bills

Total
1,522
Primary
139
Co-sponsor
1,383
This page
1,522
matching current filters
Co-sponsor HR 3642
Signed into law · United States House · Co-sponsor
Harlem Hellfighters Congressional Gold Medal Act

Harlem Hellfighters Congressional Gold Medal Act This bill provides for the award of a Congressional Gold Medal to the 369th Infantry Regiment, commonly known as the Harlem Hellfighters, in recognition of their bravery and outstanding service during World War I.

Signed into law Aug 25, 2021 1 co-sponsor
Co-sponsor HRES 589
In committee · United States House · Co-sponsor
Expressing the sense of the House of Representatives that policies governing access to medication abortion care in the United States should be equitable and based on science.

This resolution expresses the sense of the House of Representatives that policies concerning medication abortions should be grounded in science, be based on a review of medical evidence, and ensure equitable access for patients.

In committee Aug 18, 2021 1 co-sponsor
Co-sponsor HRES 591
In committee · United States House · Co-sponsor
Expressing support for the recognition of August 22 through 28, 2021, as Wildfire Preparedness Week, the national event educating the public on fire safety and preparedness, and supporting the goals of a Wildfire Preparedness Week.

This resolution supports (1) the goals of Wildfire Preparedness Week, and (2) resources and educational initiatives that communicate how affected communities can prevent wildfires and react during a wildfire.

In committee Aug 18, 2021 1 co-sponsor
Co-sponsor HR 5030
In committee · United States House · Co-sponsor
DIVERSE Trials Act

Diversifying Investigations Via Equitable Research Studies for Everyone Trials Act or the DIVERSE Trials Act This bill requires activities to increase diversity in clinical trials. It also expands reporting by laboratories that test for and diagnose COVID-19 and requires a study on data collection and data sharing during public health emergencies. Specifically, the Food and Drug Administration (FDA) must issue guidance on decentralized clinical trials to promote meaningful demographic and geographic diversity in patient engagement, enrollment, and participation. Decentralized clinical trials include those executed through telemedicine or other digital technologies to allow for the remote collection and assessment of clinical trial data. The FDA may also work with foreign regulators to harmonize international regulations governing decentralized clinical trials and the use of digital health technology. In addition, the Department of Health and Human Services (HHS) may support community education, outreach, and recruitment activities for clinical trials of treatments for conditions that disproportionately impact populations underrepresented in clinical trials. The bill also specifies that drug or device manufacturers may provide, subject to some limits, free digital health technologies and other remuneration to patients in approved clinical trials without violating laws that address fraud and abuse in federal programs. Furthermore, laboratories that test for and diagnose COVID-19 must report additional demographic data, including information about social determinants of health. HHS must also contract with the National Academy of Medicine to study and propose a design for an interoperable platform to facilitate data sharing during public health emergencies.

In committee Aug 16, 2021 1 co-sponsor
Co-sponsor HR 4833
In committee · United States House · Co-sponsor
Migratory Bird Protection Act of 2021

Migratory Bird Protection Act of 2021 This bill prohibits the incidental taking (e.g., capturing or killing) of migratory birds by commercial activities unless the activity is authorized under a permit or is identified as posing de minimis risk to migratory birds. The U.S. Fish and Wildlife Service (USFWS) must regulate such incidental taking, including by (1) issuing general permits for certain industries, (2) creating a mitigation fee for any incidental taking of migratory birds, and (3) identifying categories of de minimis risk activities that are exempt from liability for the taking of migratory birds. In addition, the USFWS must establish and maintain a research program (1) to evaluate the impacts of commercial activities on birds, (2) to evaluate the effectiveness of best management practices and technologies to avoid or minimize such impacts, and (3) to develop new or improved best management practices and technologies.

In committee Aug 14, 2021 1 co-sponsor
Co-sponsor HR 4943
In committee · United States House · Co-sponsor
Children’s Mental Health Infrastructure Act of 2021

Children's Mental Health Infrastructure Act of 2021 This bill provides funding through FY2026 to the Health Resources and Services Administration for grants to improve the capacity of children's hospitals to provide pediatric behavioral health services, including by modernizing sites of care and enhancing telehealth capabilities.

In committee Aug 9, 2021 1 co-sponsor
Co-sponsor HR 4963
In committee · United States House · Co-sponsor
Preventing Harmful Exposure to Phthalates Act

Preventing Harmful Exposure to Phthalates Act This bill prohibits the use of any phthalate chemical as a food contact substance. (A food contact substance is any substance intended for use as a component of materials used in manufacturing, packing, packaging, transporting, or holding food if such use is not intended to have a technical effect in such food.) The Food and Drug Administration (FDA) must review FDA-regulated products other than food to determine whether use of such products leads to exposure to phthalate chemicals. This review must be publicly available on the website of the Department of Health and Human Services.

In committee Aug 9, 2021 1 co-sponsor
Co-sponsor HR 4944
In committee · United States House · Co-sponsor
Helping Kids Cope Act of 2021

Helping Kids Cope Act of 2021 This bill provides funding through FY2026 to the Health Resources and Services Administration (HRSA) for grants to enhance access to and provider training in pediatric behavioral health care. Specifically, HRSA must award grants to pediatricians, children's hospitals, and other providers to support pediatric behavioral health integration and coordination within communities. Grant-funded activities may include hiring community navigators to assist families in accessing appropriate services, incorporating behavioral health services in pediatric practices, and delivering services via telehealth. In addition, HRSA must award grants to children's hospitals to expand training for providers in the pediatric behavioral health workforce.

In committee Aug 9, 2021 1 co-sponsor
Co-sponsor HR 4940
In committee · United States House · Co-sponsor
Real Corporate Profits Tax Act of 2021

Real Corporate Profits Tax Act of 2021 This bill imposes an additional 7% tax on the adjusted net book income of a corporation that exceeds $100 million. It also allows a credit for a taxpayer, other than an S corporation, for a specified percentage of the taxpayer's net regular tax liability.

In committee Aug 6, 2021 1 co-sponsor
Showing 1,261 to 1,270 of 1,522 bills